Non-obese NAFLD patients were further divided into the non-obese mild NAFLD(n=223), non-obese moderate NAFLD (n=111) and non-obese severe NAFLD(n=69) according to the value of FAP using Transient elastography. This evidence concerns the gene FAP and metabolic dysfunction-associated steatotic liver disease.